Mifepristone’s Multiple Reproductive Health Indications

With a grant from the Innovation Fund of the Reproductive Health Supplies Coalition, our team assembled a brief with information regarding four reproductive health indications for mifepristone, beyond early medical abortion. This brief reviews the current evidence around Early Pregnancy Loss, Intrauterine Fetal Death, Cervical Preparation, and Second Trimester Abortion. These additional indications for mifepristone may provide an avenue for registration of the drug in places where early medical abortion is limited. The brief is available in English and Spanish.